SuperworthPerspective Therapeutics shares outstanding CATX
Diluted shares outstanding, averaged over each quarter, from 2011.
- Latest quarter, to Jun 30, 2026
- 120.7M
- On a year earlier
- +62.5%
- more shares
Perspective Therapeutics had 120.7M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 62.5% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 74.3M | +5% |
| FY2024 | 70.8M | +152% |
| FY2023 | 28.1M | +98% |
| FY2021 | 14.2M | +108% |
| FY2020 | 6.8M | +1% |
| FY2019 | 6.7M | +21% |
| FY2018 | 5.5M | +1% |
| FY2017 | 5.5M | +0% |
| FY2016 | 5.5M | +0% |
| FY2015 | 5.5M | +1% |
| FY2014 | 5.4M | +57% |
| FY2013 | 3.5M | +15% |
| FY2012 | 3M | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 120.7M | +63% | |
| Q1 FY26 | 103.6M | +43% | |
| Q4 FY25 | 74.3M | +5% | |
| Q3 FY25 | 74.3M | +5% | |
| Q2 FY25 | 74.2M | +11% | |
| Q1 FY25 | 72.4M | +46% | |
| Q4 FY24 | 70.8M | +152% | |
| Q3 FY24 | 70.6M | +152% | |
| Q2 FY24 | 66.6M | +138% | |
| Q1 FY24 | 49.5M | +117% | |
| Q4 FY23 | 28.1M | n/a | |
| Q3 FY23 | 28.1M | n/a |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Perspective Therapeutics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.